Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic
Introduction: Cardiovascular disease is the leading cause of death worldwide. Despite the proven benefit of secondary prevention medications (SPMs), their utilisation remains suboptimal in many countries. This study aimed to assess the use of SPMs in a Malaysian primary care clinic and factors as...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academy of Family Physicians of Malaysia
2021-06-01
|
| Series: | Malaysian Family Physician |
| Subjects: | |
| Online Access: | https://e-mfp.org/wp-content/uploads/v16n2-OA-Gender-disparity.pdf |
| _version_ | 1818722023541571584 |
|---|---|
| author | Noorhida Baharudin Ahmad Muslim Ahmad Roslan Mohamed Syarif Mohamed Yassin Anis Safura Ramli Aiza Nur Izdihar Zainal Abidin Nurul Hidayatullaila Sahar Nor Shazatul Salwana Din Izyana Syazlin Ibrahim Siti Nur Hidayah Abd Rahim Nur Athirah Rosli |
| author_facet | Noorhida Baharudin Ahmad Muslim Ahmad Roslan Mohamed Syarif Mohamed Yassin Anis Safura Ramli Aiza Nur Izdihar Zainal Abidin Nurul Hidayatullaila Sahar Nor Shazatul Salwana Din Izyana Syazlin Ibrahim Siti Nur Hidayah Abd Rahim Nur Athirah Rosli |
| author_sort | Noorhida Baharudin |
| collection | DOAJ |
| description | Introduction:
Cardiovascular disease is the leading cause of death worldwide. Despite the proven benefit of secondary prevention medications (SPMs), their utilisation remains suboptimal in many countries. This study aimed to assess the use of SPMs in a Malaysian primary care clinic and factors associated with it.
Methods:
A retrospective review of electronic medical records was conducted to assess the prescription of SPMs among patients with coronary artery disease who attended the clinic between 1st January 2018 and 31st December 2018. Prescriptions of SPMs were documented in numbers and percentages. Multiple logistic regressions were used to analyse factors associated with the prescription of SPMs.
Results:
Of the 662 patients included in the study, 99.1% were prescribed statins, 97% antiplatelets, 81.7% angiotensin-converting enzyme (ACE)-inhibitors or angiotensin II receptor blockers (ARBs), and 78.7% beta-blockers. Male patients were more likely to be prescribed statins (OR = 8.584, 95% CI: 1.431 – 51.510) and antiplatelets (OR = 6.818, 95% CI: 2.294 – 20.257). Another significant factor for antiplatelets prescription was having diabetes (OR = 3.318, 95% CI: 1.148 – 9.590). Having hypertension was associated with ACE-inhibitors or ARBs prescription (OR = 4.008, 95% CI: 2.522 – 6.370).
Conclusion:
Although the majority of patients received SPMs, there were significant disparities for some SPMs prescriptions among female patients. As these medications are widely available in the Malaysian primary care setting, steps should be taken to ensure that these medications are prescribed equally for all eligible patients. |
| first_indexed | 2024-12-17T20:48:02Z |
| format | Article |
| id | doaj.art-084806a5653a409e98110d353ad422da |
| institution | Directory Open Access Journal |
| issn | 1985-2274 |
| language | English |
| last_indexed | 2024-12-17T20:48:02Z |
| publishDate | 2021-06-01 |
| publisher | Academy of Family Physicians of Malaysia |
| record_format | Article |
| series | Malaysian Family Physician |
| spelling | doaj.art-084806a5653a409e98110d353ad422da2022-12-21T21:33:06ZengAcademy of Family Physicians of MalaysiaMalaysian Family Physician1985-22742021-06-01162374410.51866/oa1080Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinicNoorhida Baharudin0Ahmad Muslim Ahmad Roslan1Mohamed Syarif Mohamed Yassin2Anis Safura Ramli3Aiza Nur Izdihar Zainal Abidin4Nurul Hidayatullaila Sahar5Nor Shazatul Salwana Din6Izyana Syazlin Ibrahim7Siti Nur Hidayah Abd Rahim8Nur Athirah Rosli9Department of Primary Care Medicine, Faculty of Medicine Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Selangor, MalaysiaIntroduction: Cardiovascular disease is the leading cause of death worldwide. Despite the proven benefit of secondary prevention medications (SPMs), their utilisation remains suboptimal in many countries. This study aimed to assess the use of SPMs in a Malaysian primary care clinic and factors associated with it. Methods: A retrospective review of electronic medical records was conducted to assess the prescription of SPMs among patients with coronary artery disease who attended the clinic between 1st January 2018 and 31st December 2018. Prescriptions of SPMs were documented in numbers and percentages. Multiple logistic regressions were used to analyse factors associated with the prescription of SPMs. Results: Of the 662 patients included in the study, 99.1% were prescribed statins, 97% antiplatelets, 81.7% angiotensin-converting enzyme (ACE)-inhibitors or angiotensin II receptor blockers (ARBs), and 78.7% beta-blockers. Male patients were more likely to be prescribed statins (OR = 8.584, 95% CI: 1.431 – 51.510) and antiplatelets (OR = 6.818, 95% CI: 2.294 – 20.257). Another significant factor for antiplatelets prescription was having diabetes (OR = 3.318, 95% CI: 1.148 – 9.590). Having hypertension was associated with ACE-inhibitors or ARBs prescription (OR = 4.008, 95% CI: 2.522 – 6.370). Conclusion: Although the majority of patients received SPMs, there were significant disparities for some SPMs prescriptions among female patients. As these medications are widely available in the Malaysian primary care setting, steps should be taken to ensure that these medications are prescribed equally for all eligible patients.https://e-mfp.org/wp-content/uploads/v16n2-OA-Gender-disparity.pdfsecondary prevention medicationsgender disparityprimary caremalaysia |
| spellingShingle | Noorhida Baharudin Ahmad Muslim Ahmad Roslan Mohamed Syarif Mohamed Yassin Anis Safura Ramli Aiza Nur Izdihar Zainal Abidin Nurul Hidayatullaila Sahar Nor Shazatul Salwana Din Izyana Syazlin Ibrahim Siti Nur Hidayah Abd Rahim Nur Athirah Rosli Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic Malaysian Family Physician secondary prevention medications gender disparity primary care malaysia |
| title | Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic |
| title_full | Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic |
| title_fullStr | Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic |
| title_full_unstemmed | Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic |
| title_short | Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic |
| title_sort | gender disparity in the prescription of secondary prevention medications in a malaysian primary care clinic |
| topic | secondary prevention medications gender disparity primary care malaysia |
| url | https://e-mfp.org/wp-content/uploads/v16n2-OA-Gender-disparity.pdf |
| work_keys_str_mv | AT noorhidabaharudin genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT ahmadmuslimahmadroslan genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT mohamedsyarifmohamedyassin genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT anissafuraramli genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT aizanurizdiharzainalabidin genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT nurulhidayatullailasahar genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT norshazatulsalwanadin genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT izyanasyazlinibrahim genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT sitinurhidayahabdrahim genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic AT nurathirahrosli genderdisparityintheprescriptionofsecondarypreventionmedicationsinamalaysianprimarycareclinic |